Peak oxygen uptake during cardiopulmonary exercise testing determines response to cardiac resynchronization therapy

Journal of Cardiology

Volumn 60, Issue 3, 2012, Pages 228-235

  Arora, Satish ^a   Aarones, Marit ^a,b   Aakhus, Svend ^a   Skaardal, Rita ^a   Aass, Halfdan ^c   Aukrust, Pål ^a,b   Kongsgaard, Erik ^a   Gullestad, Lars ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c Tonsberg Hospital   (Norway)

Author keywords

Cardiac resynchronization therapy; Cardiopulmonary exercise testing; Heart failure

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SPIRONOLACTONE;

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOPULMONARY EXERCISE TEST; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OXYGEN CONSUMPTION; PREDICTION; PROSPECTIVE STUDY; QUALITY OF LIFE; TREATMENT RESPONSE;

CARDIAC RESYNCHRONIZATION THERAPY; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 84866151462     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2012.03.004     Document Type: Article

References (29)

1. Beshai J.F., Grimm R.A., Nagueh S.F., Baker J.H., Beau S.L., Greenberg S.M., Pires L.A., Tchou P.J. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med 2007, 357:2461-2471.
2. Abraham W.T., Fisher W.G., Smith A.L., Delurgio D.B., Leon A.R., Loh E., Kocovic D.Z., Packer M., Clavell A.L., Hayes D.L., Ellestad M., Trupp R.J., Underwood J., Pickering F., Truex C., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002, 346:1845-1853.
3. Cleland J.G., Daubert J.C., Erdmann E., Freemantle N., Gras D., Kappenberger L., Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005, 352:1539-1549.
4. De Marco T., Wolfel E., Feldman A.M., Lowes B., Higginbotham M.B., Ghali J.K., Wagoner L., Kirlin P.C., Kennett J.D., Goel S., Saxon L.A., Boehmer J.P., Mann D., Galle E., Ecklund F., et al. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study. J Card Fail 2008, 14:9-18.
5. Linde C., Leclercq C., Rex S., Garrigue S., Lavergne T., Cazeau S., McKenna W., Fitzgerald M., Deharo J.C., Alonso C., Walker S., Braunschweig F., Bailleul C., Daubert J.C. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002, 40:111-118.
6. Enomoto K., Yamabe H., Toyama K., Matsuzawa Y., Yamamuro M., Uemura T., Morihisa K., Iwashita S., Kaikita K., Sugiyama S., Ogawa H. Improvement effect on endothelial function in patients with congestive heart failure treated with cardiac resynchronization therapy. J Cardiol 2011, 58:69-73.
7. Epstein A.E., DiMarco J.P., Ellenbogen K.A., Estes N.A., Freedman R.A., Gettes L.S., Gillinov A.M., Gregoratos G., Hammill S.C., Hayes D.L., Hlatky M.A., Newby L.K., Page R.L., Schoenfeld M.H., Silka M.J., et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008, 117:e350-e408.
8. Foley P.W., Leyva F., Frenneaux M.P. What is treatment success in cardiac resynchronization therapy?. Europace 2009, 11(Suppl. 5):v58-v65.
9. Chung E.S., Leon A.R., Tavazzi L., Sun J.P., Nihoyannopoulos P., Merlino J., Abraham W.T., Ghio S., Leclercq C., Bax J.J., Yu C.M., Gorcsan J., St John S.M., De Sutter J., Murillo J. Results of the predictors of response to CRT (PROSPECT) trial. Circulation 2008, 117:2608-2616.
10. Albouaini K., Egred M., Alahmar A., Wright D.J. Cardiopulmonary exercise testing and its application. Postgrad Med J 2007, 83:675-682.
11. Gibbons R.J., Balady G.J., Bricker J.T., Chaitman B.R., Fletcher G.F., Froelicher V.F., Mark D.B., McCallister B.D., Mooss A.N., O'Reilly M.G., Winters W.L., Gibbons R.J., Antman E.M., Alpert J.S., Faxon D.P., et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol 2002, 40:1531-1540.
12. Corra U., Mezzani A., Bosimini E., Giannuzzi P. Cardiopulmonary exercise testing and prognosis in chronic heart failure: a prognosticating algorithm for the individual patient. Chest 2004, 126:942-950.
13. Mancini D.M., Eisen H., Kussmaul W., Mull R., Edmunds L.H., Wilson J.R. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991, 83:778-786.
14. Auricchio A., Stellbrink C., Butter C., Sack S., Vogt J., Misier A.R., Bocker D., Block M., Kirkels J.H., Kramer A., Huvelle E. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol 2003, 42:2109-2116.
15. Cazeau S., Leclercq C., Lavergne T., Walker S., Varma C., Linde C., Garrigue S., Kappenberger L., Haywood G.A., Santini M., Bailleul C., Daubert J.C. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001, 344:873-880.
16. Mehra M.R., Kobashigawa J., Starling R., Russell S., Uber P.A., Parameshwar J., Mohacsi P., Augustine S., Aaronson K., Barr M. Listing criteria for heart transplantation: international society for heart and lung transplantation guidelines for the care of cardiac transplant candidates - 2006. J Heart Lung Transplant 2006, 25:1024-1042.
17. Epstein A.E., DiMarco J.P., Ellenbogen K.A., Estes N.A., Freedman R.A., Gettes L.S., Gillinov A.M., Gregoratos G., Hammill S.C., Hayes D.L., Hlatky M.A., Newby L.K., Page R.L., Schoenfeld M.H., Silka M.J., et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collabration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008, 117:e350-e408.
18. Loge J.H., Kaasa S. Short form 36 (SF-36) health survey: normative data from the general Norwegian population. Scand J Soc Med 1998, 26:250-258.
19. Stevens D., Elpern E., Sharma K., Szidon P., Ankin M., Kesten S. Comparison of hallway and treadmill six-minute walk tests. Am J Respir Crit Care Med 1999, 160:1540-1543.
20. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., Picard M.H., Roman M.J., Seward J., Shanewise J.S., Solomon S.D., Spencer K.T., Sutton M.S., Stewart W.J. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463.
21. Palmieri V., Russo C., Buonomo A., Cimmino G., Tartaglione D., Pezzullo S., Celentano A. Test-re-test reproducibility of Doppler echocardiography for assessment of electromechanical dyssynchrony: implications for heart failure clinic. J Cardiol 2010, 56:271-279.
22. Bristow M.R., Saxon L.A., Boehmer J., Krueger S., Kass D.A., De Marco T., Carson P., DiCarlo L., DeMets D., White B.G., DeVries D.W., Feldman A.M. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004, 350:2140-2150.
23. Versteeg H., Schiffer A.A., Widdershoven J.W., Meine M.M., Doevendans P.A., Pedersen S.S. Response to cardiac resynchronization therapy: is it time to expand the criteria?. Pacing Clin Electrophysiol 2009, 32:1247-1256.
24. Mancini D., LeJemtel T., Aaronson K. Peak VO(2): a simple yet enduring standard. Circulation 2000, 101:1080-1082.
25. Aaronson K.D., Mancini D.M. Is percentage of predicted maximal exercise oxygen consumption a better predictor of survival than peak exercise oxygen consumption for patients with severe heart failure?. J Heart Lung Transplant 1995, 14:981-989.
26. Zhang Q., Yu C.M. Is mechanical dyssynchrony still a major determinant for responses after cardiac resynchronization therapy?. J Cardiol 2011, 57:239-248.
27. Stevenson L.W., Steimle A.E., Fonarow G., Kermani M., Kermani D., Hamilton M.A., Moriguchi J.D., Walden J., Tillisch J.H., Drinkwater D.C. Improvement in exercise capacity of candidates awaiting heart transplantation. J Am Coll Cardiol 1995, 25:163-170.
28. Florea V.G., Henein M.Y., Anker S.D., Francis D.P., Chambers J.S., Ponikowski P., Coats A.J. Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure. Eur Heart J 2000, 21:146-153.
29. Maass A.H., Buck S., Nieuwland W., Brugemann J., van Veldhuisen D.J., Van Gelder I.C. Importance of heart rate during exercise for response to cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2009, 20:773-780.